Looking at the chart above, SHY's low point in its 52 week range is $84.14 per share, with $84.84 as the 52 week high point - that compares with a last trade of $84.15. Comparing the most recent share price to the 200 day moving average can also be a useful technical analysis tech...
Moderna reported a wider loss than expected for the fourth quarter on Friday morning, and the drugmaker's sales forecast for 2025 also came in below estimates. The COVID vaccine maker reported revenue of $966 million for the final quarter of 2024, down 65% year-over-year, but in line wi...
Pfizer raised its forecast on revenues from COVID-19 vaccine in 2022 by 1 billion dollars to 32 billion dollars, which is still lower than FactSet consensus estimate of 34.8 billion dollars and 33.79 billion dollars of consensus forecast released by market data supplier Refinitiv. Antivirus pill...